You just read:

Regeneron and Sanofi Announce Positive Topline Pivotal Results for PD-1 Antibody Cemiplimab in Advanced Cutaneous Squamous Cell Carcinoma

News provided by

Regeneron Pharmaceuticals, Inc.

Dec 13, 2017, 00:01 EST